πŸ“Š This is a profile preview from the Tablestat.com Platform Request a Free Trial Now

Valuation Trading Multiples & Precedent Transactions: Animal Health and Pet Care Manufacturers

Valuation benchmarks for Animal Health and Pet Care Manufacturers. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.

1.1 - Animal Health and Pet Care Manufacturers Market Context & Valuation Drivers

Companies in this public trading comparables group develop and market animal health products spanning veterinary medicines, vaccines, diagnostics, supplements, and pet care consumables for companion animals and livestock. They monetize through branded product sales to veterinarians, distributors, retail and e-commerce channels. They are comparable for valuation benchmarks given similar regulatory profiles, R&D-driven pipelines, consumable mix, and exposure to the global animal health demand cycle.

Typical capabilities include discovery and manufacturing of prescription and OTC veterinary therapeutics, parasiticides and biologics; vaccine development and commercialization; diagnostic assays and genetic testing for disease detection and herd management; formulation of nutritional, joint, immune and gastrointestinal support products; GMP manufacturing and quality; regulatory affairs; multi-channel distribution through veterinary clinics, farm channels, retail and online; and brand management and category merchandising.

Primary customers include veterinary clinics and animal hospitals, livestock producers and agribusinesses, as well as retailers and pet owners via distributors and e-commerce. Key valuation metrics include organic revenue growth, gross and EBITDA margins, recurring consumables mix and customer retention, product approval cadence and pipeline productivity, and geographic channel penetration. These drivers support pricing power and cash flow visibility for comparable company analysis and valuation benchmarks.

2. Valuation Analysis: Public Trading Comps & Multiples for Animal Health and Pet Care Manufacturers companies

2.1 - Public Peer Groups & Median Valuation Multiples for Animal Health and Pet Care Manufacturers sector

Description: Companies in this public trading comparables group develop and market animal health products spanning veterinary medicines, vaccines, diagnostics, supplements, and pet care consumables for companion animals and livestock. They monetize through branded product sales to veterinarians, distributors, retail and e-commerce channels. They are comparable for valuation benchmarks given similar regulatory profiles, R&D-driven pipelines, consumable mix, and exposure to the global animal health demand cycle.
Vetoquinol logo

Vetoquinol

Website β€’ HQ: France
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of veterinary drugs and non-medicinal products dedicated to improving animal health and well-being, focusing on the development, production, and marketing of innovative solutions for pets and livestock.
  • Key Products:
  • Companion Animal Products: Comprehensive range of medical products for cats and dogs
  • Livestock Products: Medical products for cattle and pigs
  • Joint Support: Solutions for joint health and mobility
  • Immune Support: Products to boost the immune system of pets and livestock
  • Gastrointestinal Support: Treatments for digestive health.
Zoetis logo

Zoetis

Website β€’ HQ: United States
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of animal health products, offering medicines, vaccines, diagnostic products, biodevices, and genetic tests to support the care and well-being of livestock and companion animals through innovative solutions and services globally.
  • Key Products:
  • Livestock medicines: Treatments for cattle, swine, poultry, fish, and sheep
  • Companion animal products: Healthcare solutions for dogs, cats, and horses
  • Vaccines: Protective immunization for various animal species
  • Diagnostic products: Tools for accurate disease detection and monitoring
  • Genetic testing: DNA-based diagnostic tests for animal breeding and health
πŸ”’
πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all 3 companies in this group
Request Free Trial Now β†’
πŸ”’
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

2.3 - Precedent M&A Transactions & Implied Enterprise Values for the Animal Health and Pet Care Manufacturers secto

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

3. Potential Strategic Acquirers for Animal Health and Pet Care Manufacturers

3.1 Top Strategic Buyers in Animal Health and Pet Care Manufacturers

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

3.2 - Strategic Buyer Groups & Adjacent Industry and Verticals to the Animal Health and Pet Care Manufacturers sector

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

4. Financial Sponsors & Private Equity in Animal Health and Pet Care Manufacturers

4.1 - Buyout Funds active in Animal Health and Pet Care Manufacturers

Buyout Funds investing in Animal Health and Pet Care Manufacturers companies

50+ funds
Description: Buyout funds focused on Animal Health and Pet Care Manufacturers companies globally.

4.2 - 4.2 - Growth Capital & Late-Stage Investorsin Animal Health and Pet Care Manufacturers sector

Growth Equity Funds in Animal Health and Pet Care Manufacturers companies

40+ funds
Description: Growth equity funds focused on Animal Health and Pet Care Manufacturers companies globally.
πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

Valuation FAQ: Animal Health and Pet Care Manufacturers

What is the current median EV/Revenue multiple for Animal Health and Pet Care Manufacturers?

Based on our index of public trading comparables, the median Enterprise Value to Revenue (EV/Rev) multiple for the Animal Health and Pet Care Manufacturers sector is currently ●.●x. High-growth peers in the top quartile are trading at ●●.●x. View full data.

What is the average EV/EBITDA multiple for companies in this sector?

Profitable companies in the Animal Health and Pet Care Manufacturers sector trade at a median EV/EBITDA multiple of ●●.●x. This represents a change vs the 5-year historical average. Our platform tracks EBITDA multiples for Animal Health and Pet Care Manufacturers and other key peer groups.

How have valuation multiples for Animal Health and Pet Care Manufacturers trended over the last 5 years?

Valuations have adjusted since 2021. The sector saw peak multiples of ●●.●x EV/Revenue, settling to a 5-year average of ●.●x today. Access our Historical Trends chart for granular monthly data.

What are recent M&A transaction multiples in the Animal Health and Pet Care Manufacturers space?

Recent precedent transactions indicate implied enterprise values ranging from ●.●x to ●●.●x Revenue. Private market deals often trade at a liquidity discount compared to public peers. Unlock the full list of precedent transactions.

Which public companies are used as trading comps for Animal Health and Pet Care Manufacturers?

The primary trading comparable group includes Animal Health and Pet Care Manufacturers. Key constituents used for benchmarking include large-cap leaders and specialized mid-cap players. See the full list of companies in the Public Trading Comps section.

How do I value a private company in the Animal Health and Pet Care Manufacturers sector?

Valuing a private Animal Health and Pet Care Manufacturers company typically involves applying current EV/Revenue and EV/EBITDA multiples from public peers to the private company's financial metrics. A discount for lack of marketability (DLOM) of 20-30% is often applied. Our private company valuation database provides the exact multiples needed for this calculation.

What are the Animal Health and Pet Care Manufacturers industry valuation multiples for 2025?

For 2025, the Animal Health and Pet Care Manufacturers industry is trading at a median EV/Revenue multiple of ●.●x. This reflects current market sentiment, interest rates, and growth expectations. Access our platform to see how these multiples have changed from 2024 to 2025.

What is the difference between trading comps and transaction multiples for Animal Health and Pet Care Manufacturers?

Trading comps look at how public markets value similar companies today, while transaction multiples (or precedent transactions) look at the price paid in past M&A deals. Transaction multiples often include a "control premium," typically resulting in higher valuations than trading comps. Our database tracks both trading multiples and M&A transaction multiples.

Ready to Find Valuation benchmarks?

Access complete buyer lists, valuation data, and M&A intelligence for Animal Health and Pet Care Manufacturers

Launch login modal Launch register modal